united states cbdc People searches

Qianyuan Medicine established a research and development company in Shanghai. According to the enterprise search APP, Qianyuan Medicine Research and Development (Shanghai) Co., Ltd. was recently established, with Mao Rengang as the legal representative and a registered capital of 10 million yuan. Its business scope includes: medical research and experimental development; Technical service, technical development, technical consultation, technical exchange, technology transfer and technology popularization. Enterprise investigation shows that the company is wholly owned by Qianyuan Medicine.ZTE Commercial: At present, the occupancy rate of office is about 95%, and the occupancy rate of catering industry exceeds 98%. ZTE Commercial said in the investigation of the reception organization that the company's property leasing mainly includes two parts: one is the leasing operation of catering industry in the business premises; The second is the lease operation of business office. At present, the rental rate of writing room is about 95%, and the rental rate of catering industry is over 98%. In the future, the company will focus on the main business, intensive cultivation, pioneering and innovative. On the one hand, continue to do a good job in the operation of physical stores and consolidate and strengthen the leading position in the region; On the other hand, accelerate the innovation of business model and realize new profit growth points. First, speed up the dinosaur museum project and create a new business format integrating museum and business; Second, speed up the online expansion. On the basis of the current "Zhongxing Building+"applet and live broadcast in Tik Tok, we will try to cooperate with a tripartite organization with the advantages of supply chain resources, explore a new online operation mode, and develop online and offline with the same frequency resonance and omni-channel.How to "bargain" the price difference of Chinese patent medicines? According to CCTV news, the National Medical Insurance Bureau responded that the price of proprietary Chinese medicines is affected by many factors, including the price of medicinal materials, production technology and brand value, in view of the large price difference of proprietary Chinese medicines and the problem of "bargaining". Centralized purchasing effectively squeezes the inflated price of drugs and improves the efficiency of capital use through market-oriented bidding and price-volume linkage. At the same time, the medical insurance bureau will strengthen monitoring and supervision to ensure the quality and supply of drugs and protect the rights and interests of patients.

German police searched Adidas' office and conducted a tax investigation. As part of the tax investigation that lasted for several years, German police searched Adidas' German headquarters on December 10th. An Adidas spokesperson said that the search operation involved customs and tax clearance regulations for goods imported into Germany from 2019.The turnover of Shanghai and Shenzhen stock markets exceeded 500 billion.Low-priced stocks were active repeatedly, and Mei Yan walked out of four boards in five days. In addition, more than 20 constituent stocks such as Pingtan Development, Smart Agriculture, Jin Zhengda, Zhongnan, Xiamen Industrial Co., Ltd. and Yabo Co., Ltd. had daily limit.

FTSE China A50 index futures opened 0.04% higher, and closed down 0.05% in the last session.Facewall Intelligence has received a new round of financing of several hundred million yuan. Recently, Facewall Intelligence has completed a new round of financing of several hundred million yuan. This round of financing was jointly led by Loongson Venture Capital, Dinghui Baifu, Zhongguancun Science City Fund and Safran Investment Fund, and Beijing Artificial Intelligence Industry Investment Fund and Zero2IPO followed suit.Shanghai Electric discussed new energy cooperation with South Korea's Hyosung Group. According to Shanghai Electric, on the morning of December 9, Leo, Party Secretary and Chairman of Shanghai Electric Group, went to Seoul, South Korea to visit South Korea's Hyosung Group and held talks with its president Zhao Xianjun. The two sides had in-depth exchanges on joint ventures and cooperation in the field of new energy. Zhao Xianjun expressed the hope that the two sides will strengthen cooperation in the fields of wind power and hydrogen energy and jointly explore Korean and overseas markets. During the talks, the two sides also discussed the cooperation potential in the fields of hydrogen energy and power grid equipment, and sought cooperation opportunities in technology research and development, project investment and market development.